All into Account: ‘The broader impact of GLP-1s’ with Chris Schott, Robbie Marcus, Andrea Teixeira, Ken Goldman, Brett Gibson, and Carla Casella

We expect GLP-1s will be an important theme now and in the years to come, so we’ve gathered up both the Stock and Credit analysts for a number of sectors including Pharmaceuticals, Med Tech, Food, Beverages, Healthcare, Insurance, Retail etc. to get an overview of the broad impact.   Speakers: Thomas Salopek, Head of Global Cross Asset Strategy Chris Schott, Pharmaceuticals Analyst Robbie Marcus, Medical Supplies & Devices Analyst Andrea Teixeira, Beverage, Household & Personal Care Products Analyst Ken Goldman, Food Producers & Retailers Analyst Brett Gibson, US Credit Analyst: Healthcare and Insurance Carla Casella, US Credit Analyst: Food, Beverages, Tobacco, Consumer products, Retail   This podcast was recorded on Nov 01, 2023. This communication is provided for information purposes only. Institutional clients can view the related reports at  https://www.jpmm.com/research/content/GPS-4537812-0, https://www.jpmm.com/research/content/GPS-4532586-0, for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2023 JPMorgan Chase & Co. All rights reserved.

There are no comments yet.

Please log in to write the first comment.